BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1926004)

  • 1. [Colorectal cancers: adjuvant therapy and after care (including tumor markers)].
    Laffer U; Harder F
    Ther Umsch; 1991 Jul; 48(7):449-55. PubMed ID: 1926004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.
    Bijelic L; Yan TD; Sugarbaker PH
    Ann Surg Oncol; 2007 Aug; 14(8):2281-8. PubMed ID: 17503156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adjuvant therapy of colorectal cancers].
    Joensuu H; Kellokumpu I
    Duodecim; 1997; 113(8):705-13. PubMed ID: 11466869
    [No Abstract]   [Full Text] [Related]  

  • 4. [Modalities and interest in followup of colorectal cancers after curative surgery].
    Elloumi H; Arfaoui D; Ajmi S
    Tunis Med; 2004 Feb; 82(2):190-5. PubMed ID: 15185594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of the surgeon's and the hospital's caseload on survival and local recurrence after colorectal cancer surgery.
    Renzulli P; Lowy A; Maibach R; Egeli RA; Metzger U; Laffer UT
    Surgery; 2006 Mar; 139(3):296-304. PubMed ID: 16546492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer.
    Wichmann MW; Lau-Werner U; Müller C; Hornung HM; Stieber P; Schildberg FW;
    Anticancer Res; 2000; 20(6D):4953-5. PubMed ID: 11326645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer.
    Chau I; Allen MJ; Cunningham D; Norman AR; Brown G; Ford HE; Tebbutt N; Tait D; Hill M; Ross PJ; Oates J
    J Clin Oncol; 2004 Apr; 22(8):1420-9. PubMed ID: 15007086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An anticancer drug sensitivity test to determine the effectiveness of UFT as postoperative adjuvant chemotherapy for patients with stage III colorectal cancer.
    Isogai A; Nagaya M; Matsuoka H; Watanabe T; Tsukikawa S; Kubota S
    Surgery; 2007 Nov; 142(5):741-8. PubMed ID: 17981195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgery of loco-regional recurrences in colorectal cancer].
    Peracchia A; Sarli L; Pietra N; Choua O; Maggiore SM
    Ann Ital Chir; 1995; 66(1):69-83. PubMed ID: 7545359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress in adjuvant therapy for colorectal cancer].
    Kohnoe S; Kakeji Y; Maehara Y
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2488-97. PubMed ID: 12506471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemotherapy for colorectal cancer.
    Rayter Z; Leicester RJ; Mansi JL
    Ann R Coll Surg Engl; 1995 Mar; 77(2):81-4. PubMed ID: 7793820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Time to institute more active follow up after curative surgery for colorectal cancer? Wide variation of follow up and diagnostic routines].
    Smedh K
    Lakartidningen; 2003 Apr; 100(14):1230-2, 1235-6. PubMed ID: 12756651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [After care in colorectal cancer].
    Brunner H
    Wien Med Wochenschr; 1988 Jun; 138(11-12):261-3. PubMed ID: 3176505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deleted in colorectal cancer protein expression as a possible predictor of response to adjuvant chemotherapy in colorectal cancer patients.
    Gal R; Sadikov E; Sulkes J; Klein B; Koren R
    Dis Colon Rectum; 2004 Jul; 47(7):1216-24. PubMed ID: 15148649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adjuvant chemotherapy of colorectal carcinoma].
    Casali P; Licitra L; Alafaci E; Gennari L
    Ann Ital Chir; 1990; 61(5):509-13. PubMed ID: 2100969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
    Thomschke D; Kyau-Ummen B; Halbfass HJ
    Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer patterns of care in the Western Sydney and Wentworth Area Health Services.
    Barton MB; Gabriel GS; Miles S
    ANZ J Surg; 2004 Jun; 74(6):406-12. PubMed ID: 15191469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.